Developer docs
API playgroundTry for free, no card

Search company profiles

Elekta

Full company profile

uuid00063oz

Namestring
Elekta
Legal namestring
Elekta AB (publ)
Websiteurl
elekta.com
Company typeenum
Public
Founded yearint
1972
Descriptiontext

Elekta AB (publ) is a Swedish medical technology company founded in 1972, headquartered in Stockholm and listed on NASDAQ Stockholm (EKTA B). The company designs, manufactures, and services radiation therapy and radiosurgery systems used by hospitals, cancer treatment centers, and neurosurgery clinics in over 6,000 sites worldwide. Its portfolio spans linear accelerators (Versa HD, Harmony, Infinity, Evo), the MR-Linac system Elekta Unity that combines MRI with real-time radiation delivery, the Leksell Gamma Knife family for stereotactic intracranial radiosurgery, a brachytherapy suite (Studio, Flexitron, Oncentra, Xoft, Venezia, Geneva), and the Elekta ONE cloud-based oncology informatics platform (alongside MOSAIQ, Monaco, and Proknow analytics).

Elekta generates revenue through three primary streams: (1) capital equipment sales of treatment delivery hardware; (2) recurring software and cloud subscriptions under Elekta ONE/Elekta Axis Cloud; and (3) managed service and professional service contracts under the Elekta Care and Elekta Care 360 programs. Distribution is direct via regional offices in the Americas, Europe, Asia-Pacific, and Africa, targeting large hospital systems with an enterprise field sales motion. The customer base consists of acute care hospitals, dedicated cancer centers, radiation oncology departments, and neurosurgery centers serving oncology and neurological patients.

The company employs approximately 3,800 people globally. Recent strategic emphasis has been placed on AI-enhanced imaging (Iris technology on Elekta Evo), adaptive radiotherapy, and operational restructuring, with FY 2025/26 net sales of SEK 16,718 million (~$1.6B), adjusted EBIT margin of 12.3%, and operating cash flow of SEK 1,392 million. Mid-term targets through FY 2028/29 call for mid-single digit sales CAGR, 14–16% adjusted EBIT margin, and ~10% free cash flow conversion.

Short descriptiontext

Elekta AB (publ) is a Swedish medical technology company that designs and sells radiation therapy, stereotactic radiosurgery, brachytherapy, and oncology informatics systems to over 6,000 hospitals and cancer centers worldwide, generating revenue through capital equipment sales, software subscriptions, and service contracts.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiation therapy systems, stereotactic radiosurgery, brachytherapy solutions, oncology informatics, linear accelerators
Industry2 codes
1Interventional Radiology & Image-Guided Therapy Systems
CodeHLAHABAGPrimaryYes
2Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
CodeHLAHABAHPrimaryNo
NAICS code2 codes
  • Irradiation Apparatus Manufacturing334517
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Radiation Therapy Equipment
Social media profiles4 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Devices and Systems
TypeHardware Sales
Description

Sale of radiation therapy equipment including linear accelerators, MR-Linac systems, stereotactic radiosurgery systems, and brachytherapy equipment. These are capital equipment purchases typically involving direct sales, installation, and commissioning.

ainvest.com
2Oncology Software Solutions
TypeSubscription Recurring
Description

Oncology informatics software including Elekta ONE, MOSAIQ, treatment planning systems, and cloud-based services for treatment management and workflow optimization.

elekta.com
3Service and Support
TypeManaged Services
Description

Elekta Care service offerings including maintenance, technical support, software updates, and training services for installed base of equipment worldwide.

elekta.com
4Professional Services
TypeProfessional Services
Description

Clinical training, implementation services, and consulting to support adoption and optimal use of Elekta solutions.

elekta.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 14 records shown
1Elekta Unity
Description

MR-Linac system combining MRI scanner and radiation therapy for real-time tumor imaging during treatment

elekta.com
+13 more records
Core offering1 text field

Elekta designs, manufactures, and sells radiation therapy and stereotactic radiosurgery equipment, including linear accelerators (Linacs), MR-guided radiotherapy systems (Unity), Gamma Knife radiosurgery systems, brachytherapy afterloaders and applicators, and complementary oncology informatics software for treatment planning and workflow management. The company sells these solutions to hospitals, cancer treatment centers, and neurosurgery clinics worldwide, alongside related installation, training, software subscription, and ongoing service contracts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Q4 2025/26 adjusted EBIT margin of 18.9% and gross margin of 39.9% - highest of fiscal year
+2 more records
Product overview1 text field

Elekta is a medical technology company specializing in radiation therapy, stereotactic radiosurgery, and brachytherapy solutions for cancer treatment. The product portfolio is organized around several core platforms: radiation therapy systems including linear accelerators (Versa HD, Infinity, Harmony, Evo with AI-powered Iris imaging) and MR-guided systems (Unity); stereotactic radiosurgery with the Gamma Knife platform (Esprit, Icon, Perfexion, Lightning planning optimizer, and Leksell GammaPlan software); brachytherapy solutions (Studio, ImagingRing, Oncentra Brachy, Venezia, Flexitron, Geneva, and Xoft from acquisition); oncology informatics software (MOSAIQ Plaza, Elekta ONE cloud platform, Monaco planning, Proknow analytics); neurosurgery systems (Leksell Vantage and Leksell Stereotactic System); and comprehensive services (Elekta Care, Care 360, Care Community). The company serves over 6,000 hospitals worldwide and employs approximately 3,800 people globally, with headquarters in Stockholm, Sweden.

Product and service17 records
1Elekta Unity
CategoryRadiation Therapy
Description

MR-Linac system combining an advanced diagnostic MRI scanner with a radiation therapy system, enabling MRI-guided adaptive radiotherapy with real-time tumor visualization for hospitals and cancer centers.

2Elekta Versa HD
CategoryRadiation Therapy
Description

Linear accelerator system for radiation therapy offering high-precision treatment delivery across multiple cancer indications including prostate, breast, and head & neck cancers.

3Elekta Harmony
CategoryRadiation Therapy
Description

Linear accelerator system for radiation therapy designed for efficient and precise cancer treatment delivery.

4Elekta Infinity
CategoryRadiation Therapy
Description

Linear accelerator system for advanced radiation therapy treatment with high dose rate capabilities.

5Elekta Evo
CategoryRadiation Therapy
Description

CT-Linac radiation therapy system featuring AI-powered Iris imaging technology for improved tumor and organ boundary visualization during treatment.

6Elekta Esprit
CategoryStereotactic Radiosurgery
Description

Stereotactic radiosurgery system for precise, non-invasive brain tumor and neurological disorder treatment with enhanced planning and workflow capabilities.

7Leksell Gamma Knife Icon
CategoryStereotactic Radiosurgery
Description

Advanced stereotactic radiosurgery system with integrated imaging for intracranial treatments including brain tumors and functional disorders.

8Leksell Gamma Knife Perfexion
CategoryStereotactic Radiosurgery
Description

Stereotactic radiosurgery system utilizing 192 cobalt sources for precise intracranial radiation delivery.

9Elekta ONE
CategoryOncology Software
Description

Cloud-based oncology informatics platform offering treatment applications, workflow management, and interoperability across radiation therapy planning and delivery, built on Microsoft Azure.

10MOSAIQ Plaza
CategoryOncology Software
Description

Oncology information system providing an image-enabled electronic medical record unifying diverse systems and devices across the cancer care team.

11Elekta Studio
CategoryBrachytherapy
Description

Interventional brachytherapy platform for image-guided procedures with AI-powered contouring capabilities.

12Flexitron
CategoryBrachytherapy
Description

Brachytherapy afterloader for precise radiation delivery in cancer treatment.

13Xoft
CategoryBrachytherapy
Description

Electronic brachytherapy system using a miniaturized low-energy X-ray source for various cancer treatments.

14Leksell Vantage Stereotactic System
CategoryNeurosurgery
Description

Stereotactic head frame system for neurosurgical procedures with improved design and enhanced patient comfort.

15Elekta Care
CategoryServices
Description

Comprehensive customer service and support program offering technical support, clinical engagement, and commercial responsiveness for radiotherapy centers.

16Elekta Care 360
CategoryServices
Description

Full-service support package providing comprehensive coverage for Elekta equipment and software.

17Elekta Kaiku
CategoryLife Sciences
Description

Life sciences research platform for data management and collaboration in cancer research settings.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Multi-year strategic partnership for South Africa where Nexeva serves as Elekta's strategic partner to enhance technical support, clinical engagement, and commercial responsiveness for radiotherapy centers across both private and public healthcare sectors. The partnership combines Elekta's global radiotherapy innovation with Nexeva's local healthcare footprint to improve response times, strengthen local accountability, and support long-term sustainability of radiotherapy services in the region. Partnership was signed during the World Health Expo in Dubai.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-04-01
Description

Partnership to integrate vendor-neutral imaging and auto-contouring technologies into Elekta's radiation therapy planning platform. The integration aims to improve treatment precision and clinical workflows by combining MIM's imaging analytics with Elekta's treatment systems.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Varian is Elekta's primary direct competitor in linear accelerators (TrueBeam, Edge, Halcyon), Eclipse treatment planning, and radiosurgery. The two companies together account for the vast majority of global Linac installations, serving the same oncology centers with comparable product categories.

TypeDirect peer
Description

Accuray develops the CyberKnife radiosurgery system and TomoTherapy platform, directly competing with Elekta's Leksell Gamma Knife and Linac portfolio. They serve the same radiation oncology and neurosurgery customers with stereotactic and image-guided radiotherapy solutions.

TypeDirect peer
Description

ViewRay developed the MRIdian system, the principal competing MR-guided radiation therapy platform to Elekta's Unity. ViewRay and Elekta Unity are the only two commercial MR-Linac systems targeting the same adaptive radiotherapy clinical use cases.

TypeDirect peer
Description

Brainlab offers the ExacTrac patient positioning and radiosurgery systems, as well as surgical planning software that overlaps with Elekta's neurosurgery and radiosurgery portfolio. They compete head-to-head in intracranial and spine stereotactic radiosurgery workflows.

TypeBroad incumbent
Description

Siemens Healthineers owns Varian since 2021 and combines imaging, diagnostics, and now radiation therapy through its Varian subsidiary. The combined entity competes with Elekta across imaging, treatment planning, and Linacs while leveraging Siemens's global hospital relationships.

TypeBroad incumbent
Description

Philips has historically competed with Elekta in radiotherapy simulation, imaging, and treatment planning, and divested its Pinnacle TPS patent portfolio to Elekta in 2024. Philips remains a broad healthcare incumbent whose diagnostic imaging and oncology informatics offerings overlap with Elekta's portfolio in hospitals.

TypeDirect peer
Description

RaySearch develops RayStation and RayCare, treatment planning and oncology information systems that compete directly with Elekta's Monaco, Pinnacle, Elekta ONE, and MOSAIQ software. They license planning software to multiple Linac vendors including Varian and Elekta, making them a direct competitor in oncology informatics.

TypeBroad incumbent
Description

GE HealthCare provides diagnostic imaging (CT, MR, PET) used in radiation oncology simulation and is a broad incumbent that competes with Elekta in hospital-based oncology imaging workflows and treatment planning adjacencies.

TypeEmerging player
Description

Mevion develops compact proton therapy systems (MEVION S250i) that compete with a subset of Elekta's potential addressable market in high-end radiotherapy. While Elekta does not directly sell proton systems, Mevion represents an emerging alternative modality for cancer centers considering advanced radiotherapy investment.

TypeEmerging player
Description

RefleXion is developing biology-guided radiotherapy (BgRT) using PET signals during treatment delivery. As an emerging technology player, RefleXion represents a potential future competitive threat to Elekta's image-guided Linac portfolio by combining functional imaging with radiation delivery.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles20 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries9 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A19 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Elekta

Radiation Therapy Equipmentelekta.com

Elekta AB (publ) is a Swedish medical technology company that designs and sells radiation therapy, stereotactic radiosurgery, brachytherapy, and oncology informatics systems to over 6,000 hospitals and cancer centers worldwide, generating revenue through capital equipment sales, software subscriptions, and service contracts.

What Elekta does

Elekta AB (publ) is a Swedish medical technology company founded in 1972, headquartered in Stockholm and listed on NASDAQ Stockholm (EKTA B). The company designs, manufactures, and services radiation therapy and radiosurgery systems used by hospitals, cancer treatment centers, and neurosurgery clinics in over 6,000 sites worldwide. Its portfolio spans linear accelerators (Versa HD, Harmony, Infinity, Evo), the MR-Linac system Elekta Unity that combines MRI with real-time radiation delivery, the Leksell Gamma Knife family for stereotactic intracranial radiosurgery, a brachytherapy suite (Studio, Flexitron, Oncentra, Xoft, Venezia, Geneva), and the Elekta ONE cloud-based oncology informatics platform (alongside MOSAIQ, Monaco, and Proknow analytics).

Elekta generates revenue through three primary streams: (1) capital equipment sales of treatment delivery hardware; (2) recurring software and cloud subscriptions under Elekta ONE/Elekta Axis Cloud; and (3) managed service and professional service contracts under the Elekta Care and Elekta Care 360 programs. Distribution is direct via regional offices in the Americas, Europe, Asia-Pacific, and Africa, targeting large hospital systems with an enterprise field sales motion. The customer base consists of acute care hospitals, dedicated cancer centers, radiation oncology departments, and neurosurgery centers serving oncology and neurological patients.

The company employs approximately 3,800 people globally. Recent strategic emphasis has been placed on AI-enhanced imaging (Iris technology on Elekta Evo), adaptive radiotherapy, and operational restructuring, with FY 2025/26 net sales of SEK 16,718 million (~$1.6B), adjusted EBIT margin of 12.3%, and operating cash flow of SEK 1,392 million. Mid-term targets through FY 2028/29 call for mid-single digit sales CAGR, 14–16% adjusted EBIT margin, and ~10% free cash flow conversion.

Elekta firmographics

Firmographics
Name
Elekta
Legal name
Elekta AB (publ)
Website
https://elekta.com
Company type
Public
Founded year
1972
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Elekta AB (publ) is a Swedish medical technology company that designs and sells radiation therapy, stereotactic radiosurgery, brachytherapy, and oncology informatics systems to over 6,000 hospitals and cancer centers worldwide, generating revenue through capital equipment sales, software subscriptions, and service contracts.
Ownership category
akta.pro rank

Elekta industry classification

Industry
Product category
Radiation Therapy Equipment
NAICS
Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
akta.pro secondary industry
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)

Keywords

  • Radiation therapy systems
  • Stereotactic radiosurgery
  • Brachytherapy solutions
  • Oncology informatics
  • Linear accelerators

Where Elekta is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Offices10 records

Markets served

Elekta business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Devices and Systems: Sale of radiation therapy equipment including linear accelerators, MR-Linac systems, stereotactic radiosurgery systems, and brachytherapy equipment. These are capital equipment purchases typically involving direct sales, installation, and commissioning.
  2. Oncology Software Solutions: Oncology informatics software including Elekta ONE, MOSAIQ, treatment planning systems, and cloud-based services for treatment management and workflow optimization.
  3. Service and Support: Elekta Care service offerings including maintenance, technical support, software updates, and training services for installed base of equipment worldwide.
  4. Professional Services: Clinical training, implementation services, and consulting to support adoption and optimal use of Elekta solutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Elekta product offering

Product offering

Core offering

Elekta designs, manufactures, and sells radiation therapy and stereotactic radiosurgery equipment, including linear accelerators (Linacs), MR-guided radiotherapy systems (Unity), Gamma Knife radiosurgery systems, brachytherapy afterloaders and applicators, and complementary oncology informatics software for treatment planning and workflow management. The company sells these solutions to hospitals, cancer treatment centers, and neurosurgery clinics worldwide, alongside related installation, training, software subscription, and ongoing service contracts.

Product overview

Elekta is a medical technology company specializing in radiation therapy, stereotactic radiosurgery, and brachytherapy solutions for cancer treatment. The product portfolio is organized around several core platforms: radiation therapy systems including linear accelerators (Versa HD, Infinity, Harmony, Evo with AI-powered Iris imaging) and MR-guided systems (Unity); stereotactic radiosurgery with the Gamma Knife platform (Esprit, Icon, Perfexion, Lightning planning optimizer, and Leksell GammaPlan software); brachytherapy solutions (Studio, ImagingRing, Oncentra Brachy, Venezia, Flexitron, Geneva, and Xoft from acquisition); oncology informatics software (MOSAIQ Plaza, Elekta ONE cloud platform, Monaco planning, Proknow analytics); neurosurgery systems (Leksell Vantage and Leksell Stereotactic System); and comprehensive services (Elekta Care, Care 360, Care Community). The company serves over 6,000 hospitals worldwide and employs approximately 3,800 people globally, with headquarters in Stockholm, Sweden.

Differentiator

Problem solved

Functional benefit

Brands

  • Elekta Unity: MR-Linac system combining MRI scanner and radiation therapy for real-time tumor imaging during treatment
  • Elekta Versa HD
  • Elekta Harmony
  • Elekta Infinity
  • Elekta Evo
  • Elekta Esprit
  • Leksell Gamma Knife
  • Leksell GammaPlan
  • Elekta ONE
  • MOSAIQ
  • Elekta Studio
  • Xoft
  • Flexitron
  • Oncentra Brachy

Products and services

  • Elekta Unity MR-Linac system combining an advanced diagnostic MRI scanner with a radiation therapy system, enabling MRI-guided adaptive radiotherapy with real-time tumor visualization for hospitals and cancer centers.
  • Elekta Versa HD Linear accelerator system for radiation therapy offering high-precision treatment delivery across multiple cancer indications including prostate, breast, and head & neck cancers.
  • Elekta Harmony Linear accelerator system for radiation therapy designed for efficient and precise cancer treatment delivery.
  • Elekta Infinity Linear accelerator system for advanced radiation therapy treatment with high dose rate capabilities.
  • Elekta Evo CT-Linac radiation therapy system featuring AI-powered Iris imaging technology for improved tumor and organ boundary visualization during treatment.
  • Elekta Esprit Stereotactic radiosurgery system for precise, non-invasive brain tumor and neurological disorder treatment with enhanced planning and workflow capabilities.
  • Leksell Gamma Knife Icon Advanced stereotactic radiosurgery system with integrated imaging for intracranial treatments including brain tumors and functional disorders.
  • Leksell Gamma Knife Perfexion Stereotactic radiosurgery system utilizing 192 cobalt sources for precise intracranial radiation delivery.
  • Elekta ONE Cloud-based oncology informatics platform offering treatment applications, workflow management, and interoperability across radiation therapy planning and delivery, built on Microsoft Azure.
  • MOSAIQ Plaza Oncology information system providing an image-enabled electronic medical record unifying diverse systems and devices across the cancer care team.
  • Elekta Studio Interventional brachytherapy platform for image-guided procedures with AI-powered contouring capabilities.
  • Flexitron Brachytherapy afterloader for precise radiation delivery in cancer treatment.
  • Xoft Electronic brachytherapy system using a miniaturized low-energy X-ray source for various cancer treatments.
  • Leksell Vantage Stereotactic System Stereotactic head frame system for neurosurgical procedures with improved design and enhanced patient comfort.
  • Elekta Care Comprehensive customer service and support program offering technical support, clinical engagement, and commercial responsiveness for radiotherapy centers.
  • Elekta Care 360 Full-service support package providing comprehensive coverage for Elekta equipment and software.
  • Elekta Kaiku Life sciences research platform for data management and collaboration in cancer research settings.

Quantifiable outcome

  • Q4 2025/26 adjusted EBIT margin of 18.9% and gross margin of 39.9% - highest of fiscal year
  • +2 more outcomes

Companies that use Elekta

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Elekta technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature7 records

Elekta partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Nexeva Healthcare SolutionscoreStrategic or Co-development Partner · 1 February 2026Multi-year strategic partnership for South Africa where Nexeva serves as Elekta's strategic partner to enhance technical support, clinical engagement, and commercial responsiveness for radiotherapy centers across both private and public healthcare sectors. The partnership combines Elekta's global radiotherapy innovation with Nexeva's local healthcare footprint to improve response times, strengthen local accountability, and support long-term sustainability of radiotherapy services in the region. Partnership was signed during the World Health Expo in Dubai.
  • MIM Software Inc.coreTechnology or Integration · 1 April 2024Partnership to integrate vendor-neutral imaging and auto-contouring technologies into Elekta's radiation therapy planning platform. The integration aims to improve treatment precision and clinical workflows by combining MIM's imaging analytics with Elekta's treatment systems.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Elekta competitors and assessment

Company assessment

Direct peers

  • Varian Medical Systems (a Siemens Healthineers company): Varian is Elekta's primary direct competitor in linear accelerators (TrueBeam, Edge, Halcyon), Eclipse treatment planning, and radiosurgery. The two companies together account for the vast majority of global Linac installations, serving the same oncology centers with comparable product categories.
  • Accuray: Accuray develops the CyberKnife radiosurgery system and TomoTherapy platform, directly competing with Elekta's Leksell Gamma Knife and Linac portfolio. They serve the same radiation oncology and neurosurgery customers with stereotactic and image-guided radiotherapy solutions.
  • ViewRay: ViewRay developed the MRIdian system, the principal competing MR-guided radiation therapy platform to Elekta's Unity. ViewRay and Elekta Unity are the only two commercial MR-Linac systems targeting the same adaptive radiotherapy clinical use cases.
  • Brainlab: Brainlab offers the ExacTrac patient positioning and radiosurgery systems, as well as surgical planning software that overlaps with Elekta's neurosurgery and radiosurgery portfolio. They compete head-to-head in intracranial and spine stereotactic radiosurgery workflows.
  • RaySearch Laboratories: RaySearch develops RayStation and RayCare, treatment planning and oncology information systems that compete directly with Elekta's Monaco, Pinnacle, Elekta ONE, and MOSAIQ software. They license planning software to multiple Linac vendors including Varian and Elekta, making them a direct competitor in oncology informatics.

Broad incumbents

  • Siemens Healthineers: Siemens Healthineers owns Varian since 2021 and combines imaging, diagnostics, and now radiation therapy through its Varian subsidiary. The combined entity competes with Elekta across imaging, treatment planning, and Linacs while leveraging Siemens's global hospital relationships.
  • Philips Healthcare: Philips has historically competed with Elekta in radiotherapy simulation, imaging, and treatment planning, and divested its Pinnacle TPS patent portfolio to Elekta in 2024. Philips remains a broad healthcare incumbent whose diagnostic imaging and oncology informatics offerings overlap with Elekta's portfolio in hospitals.
  • GE HealthCare: GE HealthCare provides diagnostic imaging (CT, MR, PET) used in radiation oncology simulation and is a broad incumbent that competes with Elekta in hospital-based oncology imaging workflows and treatment planning adjacencies.

Emerging players

  • Mevion Medical Systems: Mevion develops compact proton therapy systems (MEVION S250i) that compete with a subset of Elekta's potential addressable market in high-end radiotherapy. While Elekta does not directly sell proton systems, Mevion represents an emerging alternative modality for cancer centers considering advanced radiotherapy investment.
  • RefleXion Medical: RefleXion is developing biology-guided radiotherapy (BgRT) using PET signals during treatment delivery. As an emerging technology player, RefleXion represents a potential future competitive threat to Elekta's image-guided Linac portfolio by combining functional imaging with radiation delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Elekta social profiles

Digital presence

Elekta compliance and trust

Trust signal

Compliance8 records

Elekta financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Elekta leadership team

Management profile

Number of profiles

Profiles20 records

Elekta subsidiaries and ownership

Company hierarchy

Subsidiaries9 records

Elekta funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Elekta M&A and investment

M&A and investment

M&A19 records

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elekta

What does Elekta do?

Elekta designs, manufactures, and sells radiation therapy and stereotactic radiosurgery equipment, including linear accelerators (Linacs), MR-guided radiotherapy systems (Unity), Gamma Knife radiosurgery systems, brachytherapy afterloaders and applicators, and complementary oncology informatics software for treatment planning and workflow management. The company sells these solutions to hospitals, cancer treatment centers, and neurosurgery clinics worldwide, alongside related installation, training, software subscription, and ongoing service contracts.

Is Elekta a public or private company?

Elekta is a public company. It is classified as public and is currently operating.

When was Elekta founded?

Elekta was founded in 1972. It employs 1,001 to 5,000 people.

Where is Elekta based?

Elekta is headquartered in Stockholm, Sweden, in the Europe region.

How does Elekta make money?

Four revenue lines are on record. Medical Devices and Systems are the primary driver. The others are oncology Software Solutions, service and Support and professional Services.

Who are Elekta's main competitors?

Direct peers on record are Varian Medical Systems (a Siemens Healthineers company), Accuray, ViewRay, Brainlab and RaySearch Laboratories. Broad incumbents are Siemens Healthineers, Philips Healthcare and GE HealthCare. Emerging players are Mevion Medical Systems and RefleXion Medical.

Does Elekta have an API?

No public API is recorded for Elekta.

What industry is Elekta in?

Elekta's product category is Radiation Therapy Equipment. Its primary akta.pro industry code is HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems, with a secondary code of HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim). Its NAICS code is 334517 and its SIC code is 3844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Imaging Technology NewsPromising Outcomes Patients Pancreatic Cancer RadiotherapyA study of 123 pancreatic cancer patients treated with high-dose adaptive radiotherapy on Elekta Unity reported 37.4% two-year overall survival and 76.8% local tumor control. The results are promising for patients ineligible for surgery, with ongoing evaluation and Unity Pro planned.Dagens industriElekta: ”Lovande” data från fas 2-studieElekta presented promising Phase 2 data on cognitive outcomes with Leksell Gamma Knife stereotactic radiosurgery for patients with up to 50 brain metastases. The data was presented under the leadership of Pontus Herin and Fredrik Lennander.The future of tradingElekta AB (publ): New phase 2 data show favorable cognitive outcomes with Leksell Gamma Knife in patients with up to 50 brain metastasesElekta announced new phase 2 data from a Sunnybrook study showing favorable cognitive outcomes with Leksell Gamma Knife radiosurgery in patients with up to 50 brain metastases. The study found sustained memory performance two months after treatment and no difference in time to meaningful cognitive decline between groups. The findings support expanding focal treatment to patients with higher numbers of metastases.MarketScreenerElekta presents study at ASTRO 2026 showing promising long-term resultsElekta presented a study at ASTRO 2026 from Memorial Sloan Kettering Cancer Center on 123 patients treated with high-dose MR-guided adaptive radiation therapy using Elekta Unity. After a median follow-up of over two years, overall survival was 37.4% at two years and 26.3% at three years, with 76.8% of patients free of local progression at both time points. The researchers say the results warrant further evaluation of the treatment strategy.TradingViewNew phase 2 data show favorable cognitive outcomes with Leksell Gamma Knife in patients with up to 50 brain metastasesElekta announced new phase 2 data from a Sunnybrook Health Sciences Centre study showing favorable cognitive outcomes with Leksell Gamma Knife radiosurgery in patients with up to 50 brain metastases. Results showed sustained memory performance two months after treatment and no difference in time to meaningful cognitive decline between groups. The findings support expanding focal treatment to patients with higher numbers of metastases.Dagens industriElekta presenterar nya studieresultatElekta, a radiation therapy company, showed promising long-term results for patients with localized pancreatic cancer, according to a press release on Monday evening. The results were presented on September 28, 2026.The future of tradingElekta expands adaptive radiotherapy portfolio at ASTRO conferenceElekta expanded its adaptive radiotherapy portfolio at the ASTRO conference, adding online adaptive workflows for the Harmony CT-Linac platform and introducing Prostate Guideway for adaptive HDR prostate brachytherapy. Prostate Guideway remains pre-commercial and is pending U.S. FDA 510(k) clearance and EU CE marking.The future of tradingElekta AB (publ): Elekta expands adaptive workflows across its radiotherapy portfolioElekta announced an expanded adaptive radiotherapy portfolio at ASTRO, adding online adaptive workflows to CT-Linac and brachytherapy. The portfolio now includes Elekta Harmony and Prostate Guideway, with Prostate Guideway pending U.S. FDA 510(k) clearance and EU CE marking.American Banking and Market NewsEnvista (NYSE:NVST) and Elekta (OTCMKTS:EKTAY) Head to Head ComparisonEnvista and Elekta are compared on revenue, earnings, analyst ratings, and profitability. Envista has higher revenue ($2.86B vs $1.78B) and earnings, while Elekta trades at a lower P/E ratio. Analysts favor Envista with a consensus price target of $29.86, implying 24.84% upside.TradingViewElekta expands adaptive workflows across its radiotherapy portfolioElekta announced an expanded adaptive radiotherapy portfolio at ASTRO, adding online adaptive workflows to its CT-Linac and brachytherapy platforms. The portfolio now includes adaptive capabilities for Elekta Harmony and real-time adaptive planning in prostate brachytherapy with Elekta Prostate Guideway. Prostate Guideway is pre-commercial and pending U.S. FDA 510(k) clearance and EU CE marking.